Connor JR et al. |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. |
2015 |
PLoS ONE |
pmid:25973894
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|
Dai P et al. |
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. |
2015 |
AAPS J |
pmid:25762448
|
Toblli JE et al. |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. |
2015 |
Heart Lung Circ |
pmid:25666998
|
Beguin Y and Jaspers A |
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. |
2014 |
Expert Opin Pharmacother |
pmid:25186219
|
Price E et al. |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. |
2014 |
Blood Cells Mol. Dis. |
pmid:25065855
|
Kuo KL et al. |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. |
2014 |
J. Am. Soc. Nephrol. |
pmid:24722448
|
Macdougall IC et al. |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. |
2014 |
Clin J Am Soc Nephrol |
pmid:24458078
|
Contreras C et al. |
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. |
2014 |
Eur J Nutr |
pmid:23892521
|